Johnson & Johnson (JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness

October 12, 2020 10:20 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Johnson & Johnson (NYSE: JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness.

Related vaccine stocks:

AstraZeneca (NASDAQ: AZN)
BioNTech SE (NASDAQ: BNTX)
Merck (NYSE: MRK)
Moderna (NASDAQ: MRNA)
Novavax (NASDAQ: NVAX)
Pfizer (NYSE: PFE)
Sanofi (NASDAQ: SNY)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk